toripalimab

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

toripalimab

Apr 20, 2025, 11:06 | Drugs

Loqtorzi (Toripalimab): What patients need to know?

Toripalimab (Loqtorzi) is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by…

Apr 19, 2025, 13:12 | Drugs

Toripalimab (Loqtorzi): Uses in Cancer, Side Effects, Dosage, Expectations, and More

Toripalimab is a PD-1 inhibitor, a type of immune checkpoint inhibitor that works by blocking…

Nov 29, 2024, 18:49 | Insight

Dr. Reddy’s has launched Toripalimab in India: Advancing Treatment for Nasopharyngeal Carcinoma

Reddy’s Laboratories Ltd. has announced the launch of Toripalimab, the first and only immuno-oncology drug…

Aug 31, 2024, 12:58 | Insight

Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study

Eric Singhi shared a post on LinkedIn: "It’s always a pleasure to collaborate with my…

Jun 5, 2024, 12:44 | Blog

Tom Powles: Perhaps the most important long-term bladder cancer data at ASCO24

Tom Powles, Director of Barts Cancer Center, shared on X/Twitter: ''Perhaps the most important long-term…

All: 5 Posts: 1 - 100

'

Who From Oncology is Featured in TIME100 Health 2025?

'

Francesco Acerbi and Testicular Cancer: The Defender's Fight and Triumphant Return to Football

'

Yvonne Award for Breakthrough Research 2024 Recipient to Time100 Health List

'

Dr Saunthari Somasundaram is the new President-Elect of the NCD Alliance

'

Does Plastic Cause Cancer? Myths and Facts

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023